Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation-Reference-Cited by-同舟云学术

Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation

Published:2019-02-21 Issue:1 Volume:20 Page:
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

Velloso Fernando J.,Campos Alexandre R.,Sogayar Mari C.,Correa Ricardo G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Link

http://link.springer.com/content/pdf/10.1186/s12864-019-5523-6.pdf

Reference137 articles.

1. IARC. World Cancer report 2014: World Health Organization; 2014. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. https://doi.org/10.3322/caac.21442 .

3. Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, et al. Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomark Prev. 2012;21:1848–55. https://doi.org/10.1158/1055-9965.EPI-12-0474 .

4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429–34. https://doi.org/10.1158/1078-0432.CCR-06-3045 .

5. Melzer C, von der Ohe J, Hass R. Breast carcinoma: from initial tumor cell detachment to settlement at secondary sites. Biomed Res Int. 2017;2017:1–11. https://doi.org/10.1155/2017/8534371 .

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning;BioMedInformatics;2024-05-22

2. Role and molecular mechanism of NOD2 in chronic non-communicable diseases;Journal of Molecular Medicine;2024-05-14

3. Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease;Frontiers in Endocrinology;2024-03-21

4. Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review);International Journal of Oncology;2024-03-08

5. The Virtual Screening of Compounds from the ZINC Database against PARP‐1 in Triple‐Negative Breast Cancer;ChemistrySelect;2024-03-08